Dry eyes aggravated and Seborrheic dermatitis
Seborrheic dermatitis is reported only by a few people with Dry eyes aggravated.
The study analyzes which people have Seborrheic dermatitis with Dry eyes aggravated. It is created by eHealthMe based on 2 people who have Seborrheic dermatitis and Dry eyes aggravated from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who have Dry Eyes Aggravated and Seborrheic Dermatitis are studied.
What is Dry eyes aggravated?
Dry eyes aggravated is found to be associated with 787 drugs and 388 conditions by eHealthMe.
What is Seborrheic dermatitis?
Seborrheic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp) is found to be associated with 662 drugs and 603 conditions by eHealthMe.
Number of Seborrheic dermatitis in Dry eyes aggravated reports submitted per year:
Gender of people who have Dry Eyes Aggravated and experienced Seborrheic Dermatitis *:
- female: 100 %
- male: 0.0 %
Age of people who have Dry Eyes Aggravated and experienced Seborrheic Dermatitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common co-existing conditions for these people *:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 50.00%
- Migraine (headache): 1 person, 50.00%
- High Blood Pressure: 1 person, 50.00%
- Hair Loss: 1 person, 50.00%
- Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 50.00%
- Fungal Infection: 1 person, 50.00%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 50.00%
- Breast Cancer: 1 person, 50.00%
Common drugs taken by these people *:
- Zomig: 1 person, 50.00%
- Xanax: 1 person, 50.00%
- Tessalon: 1 person, 50.00%
- Synthroid: 1 person, 50.00%
- Phenergan: 1 person, 50.00%
- Flexeril: 1 person, 50.00%
- Eliquis: 1 person, 50.00%
- Demerol: 1 person, 50.00%
- Ambien: 1 person, 50.00%
Common symptoms for these people *:
- Visual Impairment: 1 person, 50.00%
- Rashes (redness): 1 person, 50.00%
- Dry Skin: 1 person, 50.00%
- Application Site Pruritus (application site severe itching of the skin): 1 person, 50.00%
- Application Site Erythema (redness of the skin at application site): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Seborrheic dermatitis?Check whether Seborrheic dermatitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Seborrheic dermatitis:
- Seborrheic dermatitis in Moderna COVID Vaccine
- Seborrheic dermatitis in Pfizer BioNTech Covid Vaccine
- Seborrheic dermatitis in Johnson and Johnson Covid Vaccine
Common drugs associated with Seborrheic dermatitis:
All the drugs that are associated with Seborrheic dermatitis:
- Seborrheic dermatitis (662 drugs)
Common conditions associated with Seborrheic dermatitis:
- Alopecia: 339 reports
- Baldness: 339 reports
- Hair loss: 339 reports
- Hair thinning: 339 reports
- Psoriasis: 139 reports
All the conditions that are associated with Seborrheic dermatitis:
- Seborrheic dermatitis (603 conditions)
How the study uses the data?
The study is based on Seborrheic dermatitis and Dry eyes aggravated, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyrtec and Apremilast drug interaction - a second ago
- Moxifloxacin and Brain Herniation - 2 seconds ago
- Aspirin and Subarachnoid Haemorrhage - 3 seconds ago
- Pemetrexed Disodium and Pantoprazole Sodium drug interaction - 3 seconds ago
- Indomethacin and Clostridium Difficile Colitis - 6 seconds ago
- Chestnut and Consciousness - Decreased - 7 seconds ago
- Xalkori and Haemorrhagic Stroke - 12 seconds ago
- Xyrem and Allergic Sinusitis - 16 seconds ago
- Furosemide and Joint Contracture - 16 seconds ago
- Oncovin and Nerve Injury - 17 seconds ago